Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended December 31, 2023 in the Board Meeting to be held on February 13, 2024 and to consider any other business with the permission of the Chair.